Skip to main content

2021 PDA/FDA Joint Regulatory Conference Main banner

Tweets by 2021 PDA/FDA Joint Regulatory Conference

Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

Browse by Speaker

Browse by Speaker

Type here to filter the list

All
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

M
Markovic, Ingrid

U.S. FDA
C1: Holistic Capacity Planning: Best Practices and Lessons Learned from New Therapeutic Modalities
Ingrid Markovic
Favorite
Live Q&A (C1)
Ingrid Markovic
Favorite
Marks, Peter

U.S. FDA
Bringing Bespoke Therapeutics into Being
Peter Marks
Favorite
CBER Updates
Peter Marks
Favorite
Live Q&A (P5)
Peter Marks
Favorite
Live Q&A (P6)
Peter Marks
Favorite
McMeekin, Judith

U.S. FDA
Live Q&A (P5)
Judith McMeekin
Favorite
ORA Updates
Judith McMeekin
Favorite
McShane, John

Lachman Consultant Services, Inc.
Greenfield Site Biologic Drug Substance Licensure Preparation
John McShane
Favorite
Live Q&A (B2)
John McShane
Favorite
Mendoza, Melissa

U.S. FDA
CBER Compliance Updates
Melissa Mendoza
Favorite
Live Q&A (P3)
Melissa Mendoza
Favorite
Meng, Jeffrey

U.S. FDA
Live Q&A (A4)
Jeffrey Meng
Favorite
Montgomery, Frank

AstraZeneca
Implementation of ICH Q12
Frank Montgomery
Favorite
Live Q&A (B4)
Frank Montgomery
Favorite